Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients After Treatment With Zoledronic Acid or Denosumab: A Retrospective Cohort Study
Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.b15-00385
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Pharmaceutical Society of Japan